Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
MGX
MGX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest MGX ETF News Today | Earnings, Events & Price Alerts
MGX News
Metagenomi Therapeutics Renames Company, Plans IND Submission for MGX-001 in 2026
Jan 12 2026
Globenewswire
Metagenomi Therapeutics Renames to Reflect Focus on Gene Therapy, MGX-001 IND Submission Planned for 2026
Jan 12 2026
Newsfilter
After-Hours Stock Surge: Exicure Leads with 72% Increase, Followed by Wave Life and Assembly Biosciences
Dec 09 2025
NASDAQ.COM
Amazon's Custom Chips Present a New Challenge for Nvidia
Dec 02 2025
WSJ
Biotech Stocks Surge in After-Hours Trading with Gains from BioAtla, Entero, and Sonnet
Dec 01 2025
NASDAQ.COM
Metagenomi (MGX) Posts Q3 Loss, Falls Short of Revenue Projections
Nov 11 2025
NASDAQ.COM
KalVista Pharmaceuticals, Inc. (KALV) Announces Q3 Loss While Exceeding Revenue Projections
Nov 10 2025
NASDAQ.COM
Biotech Claims Amazon's Alexa Chips Outperform Nvidia in Disease Combatting Capabilities
Oct 22 2025
TipRanks
Metagenomi to Utilize Amazon's Chips for Gene-Editing Technologies
Oct 22 2025
SeekingAlpha
Reasons to Consider Metagenomi (MGX) as a Strong Momentum Stock Investment
Oct 20 2025
NASDAQ.COM
Chardan Capital Maintains Buy on Metagenomi, Lowers Price Target to $11
Aug 15 2025
Benzinga
Metagenomi (MGX) Reports Q2 Loss, Tops Revenue Estimates
Aug 12 2025
NASDAQ.COM
Sam Altman Says He 'Didn't Think' Elon Musk Would Abuse Government Power, Tesla CEO Hits Back With 'Scam Altman' Jibe
Jun 20 2025
Benzinga
Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst
Jun 18 2025
Benzinga
Insider Sale: See Remarks of $MGX Sells 6,390 Shares
Jun 10 2025
NASDAQ.COM
Insider Sale: Chief Medical Officer of $MGX Sells 5,239 Shares
Jun 10 2025
NASDAQ.COM
Show More News
